AI-based model improves cardiovascular risk stratification in hypertensive retinopathy patients, indicating the importance of retinal biomarkers in risk assessment.
Dr.Noon CVD identified elevated CVD risk in HR patients and enhanced stratification when combined with existing models. These results support the use of retinal biomarkers in CVD risk assessment and the need for multidisciplinary management.
No takes yet. Share an insight, caveat, or question.
Nam et al. (2025) studied this question.